Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950109-96-004201
Filing Date
1996-07-01
Accepted
1996-07-01 00:00:00
Documents
14
Period of Report
1996-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 177293
2 STOCK OPTION PLAN EX-10.5 20882
3 DEVELOPMENT AGREEMENT EX-10.18 159437
4 FIRST AMENDMENT TO DEVELOPMENT AGREEMENT EX-10.18(A) 4510
5 LICENSE AGREEMENT DATED 2/13/96 EX-10.19 52528
6 LICENSE AGREEMENT DATED 2/21/96 EX-10.20 56160
7 AMENDMENT NO. 1 TO LOAN AGREEMENT EX-10.21(A) 6825
8 THIRD LOAN MODIFICATION AGREEMENT EX-10.23(C) 6198
9 LETTER AGREEMENT EX-10.23(D) 2069
10 COMPUTATION OF PER SHARE EX-11 1502
11 SUBSIDIARIES OF ALKERMES EX-21 778
12 PROXY STATEMENT EX-22 88203
13 CONSENT EX-23 383
14 FINANCIAL DATA SCHEDULE EX-27 2289
  Complete submission text file 0000950109-96-004201.txt   581705
Mailing Address
Business Address 64 SIDNEY ST CAMBRIDGE MA 02139-4136 6174940171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-19267 | Film No.: 96589648
SIC: 2834 Pharmaceutical Preparations